Venous thromboembolism (VTE) is the third most common cardiovascular disease after myocardial infarction and stroke. The goal of this learning activity is to provide doctors with a comprehensive review on the role of non-vitamin K antagonist oral anticoagulants (NOACs) in the management of VTE. Upon completing this module, participants will have a better understanding of the epidemiology and burden of VTE, risk assessment and prophylaxis, anticoagulant therapy for VTE and the efficacy and safety profile of NOACs in the acute and extended treatment of VTE.
Dr Tan Jiunn Liang
Consultant Chest Physician
University Malaya Medical Centre (UMMC)
Kuala Lumpur, Malaysia
• Q&A session
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.